Nir Barzilai discusses the budget for the Tame study, which is set at $78 million. The study aims to prevent age-related diseases and mortality, with specific focuses on biomarkers and geriatric aspects. The number of subjects is planned to be 3000, potentially increasing to 3500. Ancillary studies, including immune function and COVID-19 response, will also be conducted.
